Potential Q3 movers19 Jul 2024 12:39
What are we thinking are likely to be the potential big movers during the rest of Q3, based of course on expected RNS. I've got the following: MATD, CHAR, HE1, GDR, HEX, CMET, ARC, CMET, KAV. All well financed except for CHAR, some providing better entry points than others. Anyone got any others that are worth looking at for Q3?